MLN8237 200mg 200mg | Purity Not Available
Adooq Bioscience
MLN8237 (Alisertib) is a selective Aurora kinase A inhibitor with a median IC50 of 61 nM.
More Information Supplier PageMLN8237 (Alisertib) is a selective Aurora kinase A inhibitor with a median IC50 of 61 nM.
More Information Supplier PageMLN8237 (Alisertib) is a selective Aurora kinase A inhibitor with a median IC50 of 61 nM.
More Information Supplier PageMLN8237 (Alisertib) is a selective Aurora kinase A inhibitor with a median IC50 of 61 nM.
More Information Supplier PageMK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM, respectively.
More Information Supplier PageMK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM, respectively.
More Information Supplier PageMK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM, respectively.
More Information Supplier PageMK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM, respectively.
More Information Supplier PageZSTK474 inhibits class I PI3K isoforms with IC50 of 37 nM in a cell-free assay, mostly PI3Kδ. Phase1/2.
More Information Supplier PageSB216763 is a potent and selective GSK-3 inhibitor with IC50 of 34.3 nM for GSK-3α and equally effective at inhibiting human GSK-3β. SB216763 activates autophagy.
More Information Supplier PageSB216763 is a potent and selective GSK-3 inhibitor with IC50 of 34.3 nM for GSK-3α and equally effective at inhibiting human GSK-3β. SB216763 activates autophagy.
More Information Supplier Page